1. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017; 14:e275–e444.
2. Weng LC, Preis SR, Hulme OL, et al. Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation. Circulation. 2018; 137:1027–1038.
Article
3. Hu YF, Wang HH, Yeh HI, et al. Association of single nucleotide polymorphisms with atrial fibrillation and the outcome after catheter ablation. Acta Cardiol Sin. 2016; 32:523–531.
4. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003; 299:251–254.
Article
5. Huang HD, Darbar D. Genetic risk scores for atrial fibrillation: do they improve risk estimation? Can J Cardiol. 2017; 33:422–424.
Article
6. Husser D, Adams V, Piorkowski C, Hindricks G, Bollmann A. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2010; 55:747–753.
Article
7. Rattanawong P, Chenbhanich J, Vutthikraivit W, Chongsathidkiet P. A Chromosome 4q25 variant is associated with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis. J Atr Fibrillation. 2018; 10:1666.
Article
8. Choi EK, Park JH, Lee JY, et al. Korean atrial fibrillation (AF) network: genetic variants for AF do not predict ablation success. J Am Heart Assoc. 2015; 4:e002046.
Article
9. Choe WS, Kang JH, Choi EK, et al. A genetic risk score for atrial fibrillation predicts the response to catheter ablation. Korean Cir J. 2019; 49:338–349.
Article